Lv1
28 积分 2025-08-30 加入
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
11天前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
11天前
已完结
Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials
14天前
已完结
Adrenomedullin/ FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis
20天前
已完结
Behavioral Intervention with Eye-Use Monitoring to Delay Myopia Onset and Progression in Children
21天前
已完结
Molecular Approach to Colorectal Carcinoma: Current Evidence and Clinical Application
1个月前
已完结
Colorectal cancer
1个月前
已完结
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
1个月前
已完结
Pembrolizumab Versus chemotherapy in microsatellite instability–high or mismatch repair–deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase 3 KEYNOTE-177 study
1个月前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
2个月前
已完结
皖公网安备34019202002308
